CTM01
Product Specifications
Target
Mucin
Related Pathways
Immunology/Inflammation
Bioactivity
CTM01 is a murine-derived IgG1 (or humanized IgG4) monoclonal antibody inhibitor targeting MUC1. It exhibits broad-spectrum anticancer activity against epithelial-derived solid tumors such as breast cancer, lung cancer, and ovarian cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
